ArticleBMC infectious diseases2020

Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia.

Tengiz Tsertsvadze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.